Molecular Mechanism and Current Therapies for Catecholaminergic Polymorphic Ventricular Tachycardia
The rhythmic contraction of the heart relies on tightly regulated calcium (Ca) release from the sarcoplasmic reticulum (SR) Ca release channel, Ryanodine receptor (RyR2). Genetic mutations in components of the calcium release unit such as RyR2, cardiac calsequestrin and other proteins have been show...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/77447 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Molecular Mechanism and Current Therapies for Catecholaminergic Polymorphic Ventricular Tachycardia
- Diagnostics and Surgical Treatment of Left Ventricular Aneurysm with Ventricular Tachycardia
- Accurate Detection of Paediatric Ventricular Tachycardia in AED
- ICDs in Clinical Trials: Assessment of the Effects of Omega-3 Polyunsaturated Fatty Acids from Fish Oils on Ventricular Tachycardia and Ventricular Fibrillation
- Ventricular tachycardia/fibrillation ablation : the state of the art based on the VeniceChart international consensus document /
- Tachycardias Associated with Accessory Pathways: Mechanisms and Catheter Ablation
- Explainable Parallel CNN-LSTM Model for Differentiating Ventricular Tachycardia from Supraventricular Tachycardia with Aberrancy in 12-Lead ECGs